In a groundbreaking move, Ethicon, a leading MedTech company under the Johnson & Johnson umbrella, has unveiled Ethizuia—a revolutionary hemostat solution designed to tackle challenging bleeding situations.
Ethizuia boasts a distinctive synthetic polymer technology, making it the first hemostatic matrix proven to be equally effective on both sides. This innovative patch, heralded for its adaptability, can be shaped, rolled, and customized, facilitating ease of use in both open and minimally invasive surgeries.
Clinical trials have showcased Ethizuia’s exceptional efficacy, with an impressive 80% of patients experiencing hemostasis within a mere 30 seconds—six times faster than existing commercial sealant patches.
The company’s strategic move extended beyond this product launch, as Ethicon acquired GATT Technologies in May 2022. Based in the Netherlands, GATT specializes in synthetic polymers for hemostatic and sealant products, fortifying Ethicon’s capabilities to address intricate surgical bleeding challenges.
GATT’s success story began in 2021 with the first-ever implant of its patch at the Radboud University Medical Centre in Nijmegen, the Netherlands. This marked the initiation of a multi-centre clinical trial conducted by three prominent academic medical centers in the country.
Now, with the integration of GATT’s technology, Ethicon has secured CE Mark approval for Ethizuia as an adjunctive hemostat for disruptive bleeding on internal organs (excluding cardiovascular and neurological). Anticipated to launch in EMEA in the first quarter of 2024, followed by key markets in North America, APAC, and LATAM post-regulatory approvals, Ethizuia promises to redefine hemostasis solutions globally.
Vladimir Makatsaria, Chairman of Ethicon, expressed the company’s commitment to advancing surgical solutions, stating, “Disruptive bleeding can contribute to serious complications, and with the addition of Ethizuia to our portfolio, we are well positioned to deliver critical hemostasis solutions for patients.”
Ethizuia’s entry into the medical landscape marks a significant stride in surgical innovation, promising enhanced patient safety and streamlined procedures for healthcare providers worldwide.